Hair Loss

Genetic test for hair loss launches

A test that analyses a patient’s DNA and lifestyle factors has been launched that aims to determine the cause of a patient’s hair loss to assist practitioners in recommending the most appropriate treatment approaches.

Read More »

Kerastem reports positive Phase 2 trial results

US hair loss technology provider Kerastem has confirmed that patients who underwent the Phase 2 clinical trial in early-stage hair loss achieved an increase in mean terminal hair count in men with early hair loss when compared to the control group. Based on these results, Kerastem plans to begin a Phase 3 clinical trial later this year.

Read More »